Clinical Trial Update: Monoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 2 Infection [Phase 2]

View source ↗

Summary

Phase 2 trial update on a monoclonal antibody therapy targeting chronic herpes simplex virus 2 infection; study status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Genitalis

Snippet

Sponsor: Heidelberg ImmunoTherapeutics GmbH | Conditions: Herpes Genitalis | Phase 2 | Status: COMPLETED